Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2010 Jun 1.

Published in final edited form as: Ann Surg. 2009 Jun;249(6):948–953. doi: 10.1097/SLA.0b013e3181a6cdb0

TABLE 2.

Baseline Subject Characteristics of Obese Patients With and Without T2DM

	Obese Without T2DM n = 9	Obese With T2DM n = 21
Age (yr)	37.4 ± 7.5	46.1 ± 9.2^*
Weight (kg)	121.1 ± 19.3	114.1 ± 15.3
BMI (kg/m²)	45.5 ± 7.1	45.1 ± 8.1
Fasting glucose (mmol/L)	5.34 ± 0.48	7.87 ± 1.29^*
Fasting insulin (pmol/L)	167.9 ± 86.4	195.2 ± 97.9^*
HOMA-IR	4.81 ± 2.57	8.67 ± 4.60^*
Fasting GLP-1T (pmol/L)	5.23 ± 3.60	5.99 ± 3.27
Peak GLP-1T (pmol/L)	10.1 ± 5.2	16.9 ± 11.5
Fasting ghrelin	409 ± 112	516 ± 243
Max sup ghrelin (%)	24.6 ± 13.5	15.9 ± 11.2
Nadir ghrelin (pg/mL)	315 ± 124	428 ± 177
Fasting leptin (ng/mL)	39.7 ± 11.5	34.6 ± 14.0
Fasting PYY_3–36 (pg/mL)	39.9 ± 21.1	64.1 ± 34.5^*
Peak PYY_3–36 (pg/mL)	50.2 ± 24.8	78.9 ± 39.1^*
AUC PYY_3–36 (pg/mL/min⁻¹)	30.0 ± 20.8	59.9 ± 32.2^*

Mean ± SD.

^*

Denotes significant difference between groups, P < 0.05.

Max sup ghrelin indicates maximal suppression of ghrelin; AUC, area under the curve.